Webinars and Events | April 14, 2026

PBM Transparency, Fiduciary Risk & Emerging Compliance Issues: A 2026 Update for Plan Sponsors

Recent federal legislation and regulatory activity are significantly reshaping the compliance landscape for health plan sponsors. From sweeping new pharmacy benefit manager (PBM) transparency requirements to evolving fiduciary standards and PBM disclosure obligations, these reforms will have a significant impact on plans and their pharmacy benefits.

PBM Transparency Fiduciary Risk Emerging Compliance Issues

This session discusses:

  • Recent PBM legislative reform and federal regulatory activity, including new transparency and reporting requirements
  • What these changes mean from a compliance and fiduciary perspective
  • Practical considerations for plan design, utilization management and cost control

This session translates these complex developments into practical takeaways, helping plan sponsors understand where action is required, where guidance is still evolving and how to strengthen fiduciary governance in an increasingly scrutinized environment.

Watch the webinar

 

Get the presentation slides

Speakers

Elena Lynett Elena Lynett

Elena Lynett 
SVP and National Health Compliance Leader

Pincay Eileen Pincay Eileen

Eileen Pincay, RPh 
SVP and National Pharmacy Practice Leader

Zuckerman Zuckerman

Julia Zuckerman (Moderator)
VP and Senior Consultant, Compliance

See more insights

Asia Female Pharmacist Using Digital Tablet While Taking Inventory

New Requirements for PBM Reporting and Fee Disclosures

The Consolidated Appropriations Act of 2026 makes significant reforms to pharmacy benefit manager practices. See the impact on health plan sponsors.

Compliance, Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Corporate, Pharmaceutical

Read Full Insight

Woman Using A Glp 1 Medication

A Cost-Benefit Analysis of GLP-1s

Explore GLP 1 therapy adherence and discontinuation trends and what they mean for medical trend, pharmacy spend, rebates and total health plan costs.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Pharmaceutical, Corporate, Healthcare Cost Management

Get the Infographic

Doctor With Psoriasis Patient

Q3 2025 Trends Focus: Specialty Dermatological Drugs

Learn about the rising cost of these drugs, emerging therapies for psoriasis, the biosimilar market and four cost-management strategies.

Health, Multiemployer Plans, Public Sector, Healthcare Industry, Higher Education, Architecture Engineering & Construction, Pharmaceutical, Corporate, Healthcare Cost Management

Read Full Insight

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.